B

Biohit Oyj
OMXH:BIOBV

Watchlist Manager
Biohit Oyj
OMXH:BIOBV
Watchlist
Price: 2.33 EUR 0.87% Market Closed
Market Cap: 35.2m EUR
Have any thoughts about
Biohit Oyj?
Write Note

Biohit Oyj
Investor Relations

Biohit Oyj engages in the development, manufacture, and market of diagnostic tests and analysis systems. The company is headquartered in Helsinki, Etela-Suomen. The firm operates one business segment, named Diagnostics. The Diagnostics segment offers solutions for the early diagnosis and prevention of gastrointestinal diseases. The company provides blood-sample examination based on GastroPanel for the diagnosis of stomach illnesses and associated risks, quick tests for the diagnosis of lactose intolerance and Helicobacter pylori infection in connection with gastroscopy, as well as the ColonView examination for the early detection of fecal occult intestinal bleeding, which indicates a risk of colorectal cancer. The Company’s products are used in hospitals, healthcare centers and research institutions. The company operates primarily in Europe and Asia. Furthermore, the Company is a parent of Biohit Healthcare Ltd, Biohit Healthcare Srl, Oy Finio Ab, and Vantaan Hienomekano Oy, among others.

Show more

Earnings Calls

No Earnings Calls Available

Management

Prof. Osmo Antero Suovaniemi M.D., Ph.D.
Founder, Deputy CEO, Member of Scientific Advisory Board & Director
No Bio Available
Mr. Jussi Hahtela
President & CEO
No Bio Available
Mr. Jussi Sorvo
Chief Financial Officer
No Bio Available
Graham Johnson B.Sc., BSc
Head of Global Sales & Marketing
No Bio Available
Mr. Yulia Kubacheva
Head of Diagnostics Department - Biohit Russia
No Bio Available
Mr. Ilari Patrakka Msc (Econ.)
Chief Commercial Officer
No Bio Available
Mr. Panu Hendolin Ph.D.
R&D Director
No Bio Available

Contacts

Address
ETELA-SUOMEN
Helsinki
Laippatie 1
Contacts